Kamran Safavi

Dr. Kamran Safavi


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2012 in Archives of Phytopathology and Plant Protection
Verified
Journal Article
Closed access
KSKamran Safavi
Kamran Safavi
RZReza Zareie
Reza Zareie
BTBadraldin Ebrahim Sayed Tabatabaei
Badraldin Ebrahim Sayed Tabatabaei
In nature, each plant is attacked by thousands of micro-organisms, but only small number of these micro-organisms cause disease in plants. One of the important groups of defensive genes is pathogenesis-related (PR) proteins. The importance of these proteins is especially because of their ability to fight with different kinds of micro-organisms. Thaumatin-like proteins (TLPs) belong to the PR proteins and play an important role in plant defense against pathogen invasions. In this study, thaumatin-like TLP-3 gene from 1-year-old alfalfa was transferred into tobacco plants through Agrobacterium-mediated technology. The polymerase chain reaction (PCR) and reverse-transcriptase-PCR assays confirmed the presence of TLP-3 gene and TLP-3 mRNA, respectively, in transgenic tobacco plants. The bioassay results showed the activity of TLP-3 against Alternaria alternata in transgenic tobacco plants. This is the first report of enhanced resistance to A. alternata in transgenic tobacco plants with constitutive expression of TLP-3.


31 March 2025 in Biology
Verified
Journal Article
Open access
PDF file
KSKamran Safavi
Kamran Safavi
Navid AbedpoorNavid Abedpoor
Navid Abedpoor
fatemeh hajibabaiefatemeh hajibabaie
fatemeh hajibabaie
EKElina - Kaviani
Elina - Kaviani
Diabetic cardiomyopathy (DCM), a critical complication of type 2 diabetes mellitus (T2DM), is marked by metabolic dysfunction, oxidative stress, and chronic inflammation, ultimately progressing to heart failure. This study investigated the synergistic therapeutic potential of Hippophae rhamnoides L. (sea buckthorn, SBU) extract and metformin in a mouse model of T2DM-induced DCM. T2DM was induced using a 45% high-fat-AGEs-enriched diet, followed by treatment with SBU, metformin, or their combination. Treatment effects were monitored through bioinformatic analysis, chemoinformatic prediction, behavioral testing, biochemical assays, histopathological evaluations and gene expression profiles. Based on bioinformatic analysis, we identified key hub genes involved in the diabetic cardiomyopathy including SERPINE1, NRG1, MYH11, PTH, NR4A2, NRF2, PGC1α, GPX4, ATF1, ASCL2, NOX1, NLRP3, CCK8, COX2, CCL2, PTGS2, EGFR, and oncostatin, which are pivotal in modulating the ferroptosis pathway. Furthermore, the expression of long non-coding RNAs (lncRNAs) NEAT1 and MALAT1, critical regulators of inflammation and cell death, was effectively downregulated, correlating with decreased levels of the pro-inflammatory marker oncostatin. The combined therapy significantly improved glucose regulation, reduced systemic inflammation and protected the heart from oxidative damage. Histopathological analysis revealed notable reductions in cardiac necrosis and fibrosis. Particularly, the combination therapy of SBU and metformin demonstrated a synergistic effect, surpassing the benefits of individual treatments in preventing cardiac damage. These findings highlight the potential of integrating SBU with metformin as a novel therapeutic strategy for managing DCM by targeting both metabolic and ferroptosis-related pathways. This dual intervention opens promising avenues for future clinical applications in diabetic heart disease management, offering a comprehensive approach to mitigating the progression of DCM.